These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2465007)

  • 21. Analogues of methotrexate and aminopterin with gamma-methylene and gamma-cyano substitution of the glutamate side chain: synthesis and in vitro biological activity.
    Rosowsky A; Bader H; Freisheim JH
    J Med Chem; 1991 Jan; 34(1):203-8. PubMed ID: 1992118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell.
    Seither RL; Rape TJ; Goldman ID
    Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues.
    Rosowsky A; Forsch RA; Wright JE
    J Med Chem; 2004 Dec; 47(27):6958-63. PubMed ID: 15615544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifolates in rheumatoid arthritis: a hypothetical mechanism of action.
    Baggott JE; Morgan SL; Ha TS; Alarcón GS; Koopman WJ; Krumdieck CL
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S101-5. PubMed ID: 8324932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers.
    Izbicka E; Diaz A; Streeper R; Wick M; Campos D; Steffen R; Saunders M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):993-9. PubMed ID: 19221750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.
    Baggott JE; Vaughn WH; Hudson BB
    Biochem J; 1986 May; 236(1):193-200. PubMed ID: 2431676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate polyglutamates in cultured human cells.
    Rosenblatt DS; Whitehead VM
    Adv Exp Med Biol; 1983; 163():275-85. PubMed ID: 6193690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antifolate 10-deazaaminopterin inhibits neutrophil chemotaxis and superoxide generation.
    Weber GF; Nair MG; McCord JM
    Immunopharmacol Immunotoxicol; 1991; 13(3):379-93. PubMed ID: 1658111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biologic activity of new side-chain-altered methotrexate and aminopterin analogs with dual inhibitory action against dihydrofolate reductase and folylpolyglutamate synthetase.
    Rosowsky A; Moran RG; Freisheim JH; Bader H; Forsch RA; Solan VC
    NCI Monogr; 1987; (5):145-52. PubMed ID: 3431589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate and Pralatrexate.
    Wood GS; Wu J
    Dermatol Clin; 2015 Oct; 33(4):747-55. PubMed ID: 26433846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of dihydrofolic reductase by aminopterin and amethopterin.
    OSBORN MJ; FREEMAN M; HUENNEKENS FM
    Proc Soc Exp Biol Med; 1958 Feb; 97(2):429-31. PubMed ID: 13518295
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
    McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
    Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of sulfa drugs and dihydrofolate reductase inhibitors against Candida albicans.
    Bush K; Freudenberger JS; Slusarchyk DS; Sykes RB; Meyers E
    Experientia; 1982 Apr; 38(4):436-7. PubMed ID: 7044814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxylation of 4-amino-antifolates by partially purified aldehyde oxidase from rabbit liver.
    Fabre G; Seither R; Goldman ID
    Biochem Pharmacol; 1986 Apr; 35(8):1325-30. PubMed ID: 2421732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, binding and intracellular retention of methotrexate polyglutamates by cultured human breast cancer cells.
    Schilsky RL; Jolivet J; Bailey BD; Chabner BA
    Adv Exp Med Biol; 1983; 163():247-57. PubMed ID: 6193688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PT523 and other aminopterin analogs with a hemiphthaloyl-L-ornithine side chain: exceptionally tight-binding inhibitors of dihydrofolate reductase which are transported by the reduced folate carrier but cannot form polyglutamates.
    Rosowsky A
    Curr Med Chem; 1999 Apr; 6(4):329-52. PubMed ID: 10101216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M
    Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing cytotoxic sensitivity of tumor cells to antifolates: another opportunity for gene therapy?
    Sirotnak FM
    J Natl Cancer Inst; 1999 Jul; 91(14):1178-9. PubMed ID: 10413407
    [No Abstract]   [Full Text] [Related]  

  • 40. 10-Ethyl-10-deaza-aminopterin: structural design and biochemical, pharmacologic, and antitumor properties.
    Sirotnak FM; Schmid FA; Samuels LL; DeGraw JI
    NCI Monogr; 1987; (5):127-31. PubMed ID: 2448650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.